Drug Topics e-News:
Having trouble viewing this email? View in a browser.
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
Subscribe Now
to Drug Topics e-News
Drug Topics, Voice of the Pharmacist, Hospital Pharmacists' Report
Part of the Modern Medicine Network
e-News
December 30, 2010
Drug Topics
In This Issue
Continuing Education
Newest: An update on Clostridium difficile infection
For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here
Meetings
Survey
This month we would like to know...

Would you join a pharmacists’ union?
* Absolutely not.

* Some pharmacists might need one, but I wouldn't join.

* I'm afraid to join, in case it jeopardizes my job.

* Sign me up!
Click Here to Vote
Digital Edition
Drug Topics Digital Edition
View Current Edition
Subscribe to the Digital Edition
Anzemet shown to increase risk of abnormal heart rhythm

FDA announced recently that the injection form of Anzemet (dolasetron mesylate) should no longer be used to prevent chemotherapy-induced nausea and vomiting. Read full article.

DT Blog
Speers

A discussion generated by Drug Topics’ readers, editorial staff, and advisory board
Jim Plagakis, RPh, Community Pharmacist, Galveston, TX

Stop being such a whiner - open your own store Read full article.

ARB-based therapy does not reduce mortality in setting of diabetes and hypertension

Antihypertensive therapy with an ARB is not associated with reductions in cardiovascular or all-cause mortality compared to non-ARB-based regimens in patients with type 2 diabetes, according to researchers at the Massachusetts College of Pharmacy and Health Sciences Read full article.

Switching statins leads to lower persistence with therapy

Patients who switch statins have lower persistence to therapy compared to those who don’t switch, according to a poster recently presented at the 45th midyear meeting of the American Society of Health-Systems Pharmacists. Read full article.

Higher co-pays increase possibility of early discontinuation, inadequate use of breast cancer therapy

A higher prescription co-payment, especially among older women, is associated with the early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a life-saving therapy for women with hormone-sensitive, early-stage breast cancer, research shows. Read full article.

Meetings and events

February 6-8, 2011 NACDS Regional Chain Conference
Naples, FL
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-837-4300

February 13, 2011 19th Annual WILLIAM R. BACON MEMORIAL Breakfast
6:30 a.m. - 8:45 a.m.
Palm Springs, CA
Contact:
800-333-7535; 760-325-6611

March 9-10, 2011 NACDS RxIMPACT Day on Capitol Hill
Washington, DC
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
hecker@nacds.org

March 13-15, 2011 NACDS Supply Chain & Logistics Conference
San Diego, CA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678

March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734

CEC

Contact Us
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here
 

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.